Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins
- PMID: 33430286
- PMCID: PMC7825740
- DOI: 10.3390/vaccines9010027
Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins
Abstract
The 6 kDa early secreted antigen target (ESAT6) is a low molecular weight and highly immunogenic protein of Mycobacterium tuberculosis with relevance in the diagnosis of tuberculosis and subunit vaccine development. The gene encoding the ESAT6 protein is located in the M. tuberculosis-specific genomic region known as the region of difference (RD)1. There are 11 M. tuberculosis-specific RDs absent in all of the vaccine strains of BCG, and three of them (RD1, RD7, and RD9) encode immunodominant proteins. Each of these RDs has genes for a pair of ESAT6-like proteins. The immunological characterizations of all the possible proteins encoded by genes in RD1, RD7 and RD9 have shown that, besides ESAT-6 like proteins, several other proteins are major antigens useful for the development of subunit vaccines to substitute or supplement BCG. Furthermore, some of these proteins may replace the purified protein derivative of M. tuberculosis in the specific diagnosis of tuberculosis by using interferon-gamma release assays and/or tuberculin-type skin tests. At least three subunit vaccine candidates containing ESAT6-like proteins as antigen components of multimeric proteins have shown efficacy in phase 1 and phase II clinical trials in humans.
Keywords: ESAT6-like proteins; M. tuberculosis; RD genomic segments; diagnosis; vaccine.
Conflict of interest statement
The author declares no conflict of interest.
Figures
Similar articles
-
Early secreted antigenic target of 6 kda-like proteins of mycobacterium tuberculosis: Diagnostic and vaccine relevance.Int J Mycobacteriol. 2022 Jan-Mar;11(1):10-15. doi: 10.4103/ijmy.ijmy_232_20. Int J Mycobacteriol. 2022. PMID: 35295018
-
Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.Tuberculosis (Edinb). 2005 Sep-Nov;85(5-6):367-76. doi: 10.1016/j.tube.2005.08.006. Epub 2005 Oct 25. Tuberculosis (Edinb). 2005. PMID: 16253561
-
Modulation of host immune responses by overexpression of immunodominant antigens of Mycobacterium tuberculosis in bacille Calmette-Guérin.Scand J Immunol. 2003 Oct;58(4):449-61. doi: 10.1046/j.1365-3083.2003.01321.x. Scand J Immunol. 2003. PMID: 14507310
-
Tuberculosis: looking beyond BCG vaccines.J Postgrad Med. 2003 Apr-Jun;49(2):134-40. J Postgrad Med. 2003. PMID: 12867689 Review.
-
Chemical and Biological Characterization of Mycobacterium Tuberculosis-Specific ESAT6-Like Proteins and their Potentials in the Prevention of Tuberculosis and Asthma.Med Princ Pract. 2023 Sep 13;32(4-5):217-24. doi: 10.1159/000534002. Online ahead of print. Med Princ Pract. 2023. PMID: 37703836 Free PMC article. Review.
Cited by
-
Exposure to bovine livestock and latent tuberculosis infection in children: Investigating the zoonotic tuberculosis potential in a large urban and peri-urban area of Cameroon.PLOS Glob Public Health. 2024 Aug 26;4(8):e0003669. doi: 10.1371/journal.pgph.0003669. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39186747 Free PMC article.
-
The ΔfbpAΔsapM candidate vaccine derived from Mycobacterium tuberculosis H37Rv is markedly immunogenic in macrophages and induces robust immunity to tuberculosis in mice.Front Immunol. 2024 Jun 21;15:1321657. doi: 10.3389/fimmu.2024.1321657. eCollection 2024. Front Immunol. 2024. PMID: 38975346 Free PMC article.
-
The Effect of Delivery Systems on the Induction of T Helper 1 Cell Response to an ESAT6-Like Protein Rv3619c and Identification of Its Immunodominant Peptides.Med Princ Pract. 2022;31(4):359-367. doi: 10.1159/000525136. Epub 2022 May 18. Med Princ Pract. 2022. PMID: 35584661 Free PMC article.
-
Adjuvants and Antigen-Delivery Systems for Subunit Vaccines against Tuberculosis.Vaccines (Basel). 2021 Aug 30;9(9):972. doi: 10.3390/vaccines9090972. Vaccines (Basel). 2021. PMID: 34579209 Free PMC article.
-
The combination of Mycobacterium tuberculosis fusion proteins LT33 and LT28 induced strong protective immunity in mice.Front Immunol. 2024 Nov 22;15:1450124. doi: 10.3389/fimmu.2024.1450124. eCollection 2024. Front Immunol. 2024. PMID: 39650665 Free PMC article.
References
-
- Black G.F., Weir R.E., Floyd S., Bliss L., Warndorff D.K., Crampin A.C., Ngwira B., Sichali L., Nazareth B., Blackwell J.M., et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: Two randomised controlled studies. Lancet. 2002;359:1393–1401. doi: 10.1016/S0140-6736(02)08353-8. - DOI - PubMed
-
- Martin C., Aguilo N., Marinova D., Gonzalo-Asensio J. Update on TB vaccine pipeline. Appl. Sci. 2020;10:2632. doi: 10.3390/app10072632. - DOI
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous